Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
mTORC1 and ferroptosis: Regulatory mechanisms and therapeutic potential
BioEssays ( IF 3.2 ) Pub Date : 2021-06-14 , DOI: 10.1002/bies.202100093 Guang Lei 1, 2 , Li Zhuang 2 , Boyi Gan 2, 3
BioEssays ( IF 3.2 ) Pub Date : 2021-06-14 , DOI: 10.1002/bies.202100093 Guang Lei 1, 2 , Li Zhuang 2 , Boyi Gan 2, 3
Affiliation
|
Ferroptosis, a form of regulated cell death triggered by lipid hydroperoxide accumulation, has an important role in a variety of diseases and pathological conditions, such as cancer. Targeting ferroptosis is emerging as a promising means of therapeutic intervention in cancer treatment. Polyunsaturated fatty acids, reactive oxygen species, and labile iron constitute the major underlying triggers for ferroptosis. Other regulators of ferroptosis have also been discovered recently, among them the mechanistic target of rapamycin complex 1 (mTORC1), a central controller of cell growth and metabolism. Inhibitors of mTORC1 have been used in treating diverse diseases, including cancer. In this review, we discuss recent findings linking mTORC1 to ferroptosis, dissect mechanisms underlying the establishment of mTORC1 as a key ferroptosis modulator, and highlight the potential of co-targeting mTORC1 and ferroptosis in cancer treatment. This review will provide valuable insights for future investigations of ferroptosis and mTORC1 in fundamental biology and cancer therapy.
更新日期：2021-07-23
京公网安备 11010802027423号